Picture of IntegraGen SA logo

ALINT — IntegraGen SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: IntegraGen H1 Revenue Grows To EUR 6.4 Million

July 13 (Reuters) - Integragen SA  ALINT.PA :
    * INTEGRAGEN REPORTS 6.4 MEUR IN REVENUES FOR FIRST HALF OF
2022
REPRESENTING 34% GROWTH COMPARED TO H1 2021
    * STRONG REVENUE GROWTH LINKED WITH MICROBIOLOGY SEQUENCING
    * CASH POSITION AS OF END OF JUNE 2022 WAS 4,489 KEUR , A
DECREASE
OF 0.3 MEUR COMPARED TO DECEMBER 31, 2021
    * CONFIRMS ITS GROWTH PERSPECTIVES BASED ON CURRENT SALES
DYNAMICS
AND EXISTING LONG-TERM CONTRACTS ALONG WITH SYNERGIES NOW IN
PLACE WITH OTHER ENTITIES OF ONCODNA GROUP
    * BUSINESS DRIVEN BY LONG TERM CONTRACTS FOR OPERATION OF
EXTERNAL
SEQUENCING PLATFORMS, BENEFITS FROM SOLID COMMERCIAL DYNAMICS -
CEO

Source text for Eikon:  ID:nBwbFfJ4Wa 
Further company coverage:  ALINT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on IntegraGen SA

See all news